Close Menu

NEW YORK (GenomeWeb) – Amgen and Syapse have agreed to collaborate in precision oncology, working together to develop observational research analytics tools to assess treatment outcomes and address "areas of unmet need" in cancer care, the companies said Wednesday.

Together, the companies will scan the Syapse Learning Health Network — a data-sharing network for precision oncology — to identify candidates for Amgen-sponsored clinical trials. They also will seek to extend such trials to community health centers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Dec
11
Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.